Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs BPC 157 + TB 500: what patients should know These peptides are increasingly discussed in regenerative and sports medicine due to early research in tissue repair and recovery pathwayswhich is why they've gained attention Frontiers Stable Gastric Pentadecapeptide BPC 157 and Wound Healing Breakthrough Peptide Healing: How BPC 157 & TB 500 Support Rapid Recovery at Iowa IV Iowa IV BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or